ESC 365 - Natriuretic Peptide Metabolisation is Associated with Clinical Outcome in Chronic Heart Failure: a Step Towards Personalized Heart Failure Guidance

ESC Premium Access

Natriuretic Peptide Metabolisation is Associated with Clinical Outcome in Chronic Heart Failure: a Step Towards Personalized Heart Failure Guidance

Session: Late Breaking Science in Heart Failure 2

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor R. van Kimmenade (Nijmegen, NL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Roland van Kimmenade

Radboud University Medical Centre, Nijmegen (Netherlands (The))

4 presentations

0 follower

4 more presentations in this session

Dynamic changes in cardiac structures: novel aspects of the pathophysiology of heart failure with preserved left ventricular ejection fraction -a report from the CHART-2 Study-

Speaker: Professor H. Shimokawa (Sendai, JP)

Diabetes and heart failure after acute myocardial infarction. The FAST-MI programme

Speaker: Professor N. Danchin (Paris, FR)

Current characteristics and treatment of patients with heart failure with reduced ejection fraction in outpatients in Europe.Baseline results of ARIADNE

Speaker: Professor A. Maggioni (Florence, IT)

Association between beta-blocker use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study

Speaker: Professor G. Savarese (Stockholm, SE)

Access the full session

Late Breaking Science in Heart Failure 2

Speakers: Doctor R. van Kimmenade, Professor H. Shimokawa, Professor N. Danchin, Professor A. Maggioni, Professor G. Savarese

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources